The FDA granted fast track designation for CTx001, an investigational gene therapy candidate for geographic atrophy secondary ...
Thanks to this tiny piece of tech, people with profound vision loss can now read, do cross word puzzles, and navigate public ...
Round led by new investor Life Sciences at Goldman Sachs Alternatives with participation by new investor the Retinal ...
Greenland sharks possess a DNA repair mechanism that maintains vision over centuries, preventing retinal degeneration despite ...
Enrollment in 4D-150 Phase 3 wet AMD clinical trials exceeding expectations; 4FRONT-1 trial remains on track to complete enrollment in Q1 2026, ...
Nanoscope Therapeutics Inc., a biotechnology company committed to developing and commercializing novel, disease-agnostic therapies for patients with photoreceptor loss and vision impairment due to ...
The "Geographic Atrophy Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" has been added to ResearchAndMarkets.com's offering.The global ...
Novel capsid technology to enable convenient delivery in the doctor’s office of IKAR-003 for intermediate AMD, designed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback